Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia

Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families

(2011) P. Noris et al.   BLOOD

Fatigue in adult patients with primary immune thrombocytopenia

(2011) Julia L. Newton et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura

(2009) Cindy E. Neunert et al.   PEDIATRIC BLOOD & CANCER

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

(2008) N. M. Heddle et al.   BLOOD